IGFBP5 Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of IGFBP5 monoclonal antibodies for research focused on understanding Insulin-like Growth Factor Binding Protein 5. IGFBP5 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Insulin-like Growth Factor Binding Protein 5 plays a crucial role in regulating the availability and activity of insulin-like growth factors, which are essential for cell growth, development, and metabolism. By modulating IGF signaling, IGFBP5 is implicated in various physiological processes, including cell proliferation, differentiation, and apoptosis. Research has shown IGFBP5 involvement in cancer development, obesity-related conditions, and metabolic disorders. Scientists worldwide utilize IGFBP5 monoclonal antibodies to investigate potential therapeutic strategies for these conditions. Understanding IGFBP5 function continues to reveal new insights about cellular regulation and disease mechanisms. IGFBP5 research has opened promising avenues for developing targeted treatments in multiple medical fields. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific understanding of IGFBP5 and its impact on human health.